Φορτώνει......
A Novel Adenylyl Cyclase Type 5 Inhibitor That Reduces Myocardial Infarct Size Even When Administered After Coronary Artery Reperfusion
We developed a novel adenylyl cyclase type 5 (AC5) inhibitor, C90, that reduces myocardial infarct size even when administered after coronary reperfusion. This is key, since it is not practical to administer a drug to a patient with myocardial infarction before revascularization, and is one reason w...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J Mol Cell Cardiol |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6103820/ https://ncbi.nlm.nih.gov/pubmed/29800555 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.yjmcc.2018.05.014 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|